Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus

BMC Nephrology

Volumn 10, Issue 1, 2009, Pages

  Lin, Julie ^a   Hu, Frank B ^a,b   Qi, Lu ^a,b   Curhan, Gary C ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; HEALTH PRACTITIONER; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

EID: 78650422852     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-10-9     Document Type: Article

References (37)

1. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. BM Brenner, N Engl J Med 2001 345 12 861 9 11565518 10.1056/NEJMoa011161
2. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000 355 9200 253 9 10675071 10.1016/S0140-6736(99)12323-7
3. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. T Fujisawa, Diabetologia 1998 41 1 47 53 9498629 10.1007/s001250050865
4. Ageing and plasma adiponectin concentration in apparently healthy males and females. M Adamczak, Clin Endocrinol (Oxf) 2005 62 1 114 8 15638879 10.1111/j.1365-2265.2004.02182.x
5. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. E Lovati, Kidney International 2001 60 1 46 54 11422735 10.1046/j.1523-1755.2001.00769.x
6. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. JJ Rogus, Hypertension 1998 31 2 627 31 9461232
7. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. AM Schmidt, Br J Haematol 1996 92 3 747 50 8616048 10.1046/j.1365-2141.1996.379915.x
8. Polymorphisms of angiotensin-converting enzyme and angiotensinogen genes in type 2 diabetic sibships in relation to albumin excretion rate. A Solini, American Journal of Kidney Diseases 1999 34 6 1002 9 10585308 10.1016/S0272-6386(99)70004-1
9. Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. AA Sethi, Hypertension 2003 41 6 1202 11 12743009 10.1161/01.HYP.0000072334.34433.17
10. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. BR Winkelmann, Am Heart J 1999 137 4 Pt 1 698 705 10097233 10.1016/S0002-8703(99)70226-7
11. Biological functions of angiotensin and its receptors. T Matsusaka I Ichikawa, Annual Review of Physiology 1997 59 395 412 9074770 10.1146/annurev.physiol.59.1.395
12. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. I Inoue, Journal of Clinical Investigation 1997 99 7 1786 97 9120024 10.1172/JCI119343
13. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. JC Rodriguez-Perez, J Am Coll Cardiol 2001 37 6 1536 42 11345362 10.1016/S0735-1097(01)01186-X
14. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. M Buraczynska, Kardiol Pol 2003 58 1 1 9 14502296
15. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II[see comment]. JA Miller K Thai JW Scholey, Kidney International 1999 56 6 2173 80 10594793 10.1046/j.1523-1755.1999.00770.x
16. Folate intake and the risk of incident hypertension among US women. JP Forman, Jama 2005 293 3 320 9 15657325 10.1001/jama.293.3.320
17. Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. MB Schulze, Diabetes Care 2004 27 7 1680 7 15220246 10.2337/diacare.27.7.1680
18. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. KC Abbott, American Journal of Kidney Diseases 2001 37 2 366 73 11157379 10.1053/ajkd.2001.21311
19. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. MB Schulze, Am J Clin Nutr 2005 82 3 675 84 16155283
20. Cigarette smoking, relative weight, and menopause. W Willett, Am J Epidemiol 1983 117 6 651 8 6859020
21. Recommendations for healthcare system and self-management education interventions to reduce morbidity and mortality from diabetes. Am J Prev Med 2002 22 4 Suppl 10 4 11985932
22. Prediction of creatinine clearance from serum creatinine. DW Cockcroft MH Gault, Nephron 1976 16 1 31 41 1244564 10.1159/000180580
23. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. M Tanasescu, Circulation 2003 107 19 2435 9 12719277 10.1161/01.CIR.0000066906.11109.1F
24. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. AH Danser, J Hypertens 1998 16 6 853 62 9663926 10.1097/00004872-199816060- 00017
25. Gender differences in the renal response to renin-angiotensin system blockade. JA Miller, J Am Soc Nephrol 2006 17 9 2554 60 16914541 10.1681/ASN.2005101095
26. Influence of gender and genetic variability on plasma angiotensin peptides. A Reyes-Engel, J Renin Angiotensin Aldosterone Syst 2006 7 2 92 7 17083063 10.3317/jraas.2006.015
27. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. S Fradin, Diabetes Metab 2002 28 1 27 32 11938025
28. [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes]. M Buraczynska, Pol Arch Med Wewn 2002 108 2 725 30 12476891
29. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. CS Baker, J Am Coll Cardiol 2003 41 12 2114 8 12821233 10.1016/S0735-1097(03)00487-X
30. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. TE Hunley, Kidney International 1996 49 2 571 7 8821846 10.1038/ki.1996.81
31. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. C Gutierrez, Metabolism 1997 46 8 976 80 9258285 10.1016/S0026-0495(97)90090-1
32. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. T Ohno S Kawazu S Tomono, Metabolism 1996 45 2 218 22 8596493 10.1016/S0026-0495(96)90057-8
33. Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. TY Wong, Am J Kidney Dis 1999 33 6 1064 70 10352194 10.1016/S0272-6386(99)70143-5
34. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. J Ringel, Diabetologia 1997 40 2 193 9 9049480 10.1007/s001250050662
35. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. JA Staessen, J Hypertens 1999 17 1 9 17 10100088 10.1097/00004872-199917010-00003
36. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. P Prasad, BMC Med Genet 2006 7 42 16672053 10.1186/1471-2350-7-42
37. Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study. CC Hsu, J Am Soc Nephrol 2006 17 2 504 12 16396964 10.1681/ASN.2005050468